113 related articles for article (PubMed ID: 36112751)
1. Effect of Health Disparities on Refusal of Trimodality Therapy in Localized Esophageal Adenocarcinoma: A Propensity Score Matched Analysis of the National Cancer Database.
Salti I; Petesch T; Naffouje SA; Kamarajah SK; Dahdaleh F
Am Surg; 2023 Nov; 89(11):4644-4653. PubMed ID: 36112751
[TBL] [Abstract][Full Text] [Related]
2. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
[TBL] [Abstract][Full Text] [Related]
3. Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes.
Shao MS; Wong AT; Schwartz D; Weiner JP; Schreiber D
Ann Thorac Surg; 2016 Jun; 101(6):2148-54. PubMed ID: 27016842
[TBL] [Abstract][Full Text] [Related]
4. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
5. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
6. Refusal of Local Therapy in Esophageal Cancer and Impact on Overall Survival.
Parsons M; Lloyd S; Johnson S; Scaife C; Varghese T; Glasgow R; Garrido-Laguna I; Tao R
Ann Surg Oncol; 2021 Feb; 28(2):663-675. PubMed ID: 32648178
[TBL] [Abstract][Full Text] [Related]
7. Induction chemoradiation therapy prior to esophagectomy is associated with superior long-term survival for esophageal cancer.
Speicher PJ; Wang X; Englum BR; Ganapathi AM; Yerokun B; Hartwig MG; D'Amico TA; Berry MF
Dis Esophagus; 2015; 28(8):788-96. PubMed ID: 25212528
[TBL] [Abstract][Full Text] [Related]
8. Disparities in survival after trimodality therapy for esophageal adenocarcinoma.
Eng OS; Nelson RA; Konstantinidis I; Chao J; Erhunmwunsee L; Raz DJ; Kim JY
Dis Esophagus; 2018 Sep; 31(9):. PubMed ID: 29534155
[TBL] [Abstract][Full Text] [Related]
9. Neoadjuvant chemoradiation is associated with improved overall survival in older patients with esophageal cancer.
Guttmann DM; Mitra N; Metz JM; Plastaras J; Feng W; Swisher-McClure S
J Geriatr Oncol; 2018 Jan; 9(1):40-46. PubMed ID: 28887066
[TBL] [Abstract][Full Text] [Related]
10. More than treatment refusal: a National Cancer Database analysis of adjuvant treatment refusal and racial survival disparities among women with endometrial cancer.
Barrington DA; Sinnott JA; Nixon D; Padamsee TJ; Cohn DE; Doll KM; Donneyong MM; Felix AS
Am J Obstet Gynecol; 2022 Aug; 227(2):244.e1-244.e17. PubMed ID: 35283091
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with the refusal of surgery and the associated impact on survival in patients with rectal cancer using the National Cancer Database.
Coffman AR; Tao R; Cohan JN; Huang LC; Pickron TB; Torgeson AM; Lloyd S
J Gastrointest Oncol; 2021 Aug; 12(4):1482-1497. PubMed ID: 34532104
[TBL] [Abstract][Full Text] [Related]
12. Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.
Elshabrawy A; Wang H; Satsangi A; Wheeler K; Ramamurthy C; Pruthi D; Kaushik D; Liss M; Gelfond J; Fernandez R; Gore J; Svatek R; Mansour AM
Urol Oncol; 2021 Apr; 39(4):236.e9-236.e20. PubMed ID: 33423936
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic predictors of surgery refusal in patients with stage I-III colon cancer.
Lu PW; Fields AC; Yoo J; Irani J; Goldberg JE; Bleday R; Melnitchouk N
J Surg Oncol; 2020 Jun; 121(8):1306-1313. PubMed ID: 32227344
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
Rucker AJ; Raman V; Jawitz OK; Voigt SL; Harpole DH; D'Amico TA; Tong BC
Ann Surg; 2022 Feb; 275(2):348-355. PubMed ID: 32209899
[TBL] [Abstract][Full Text] [Related]
15. Role of Perioperative Chemotherapy in Lymph Node-negative Esophageal Cancer After Resection: A Population-based Study With Propensity Score-matched Analysis.
Yang Y; Zhou X; Tang L; Xu X; Du X; Qiu G
Am J Clin Oncol; 2019 Dec; 42(12):924-931. PubMed ID: 31651453
[TBL] [Abstract][Full Text] [Related]
16. Race and Health Disparities in Patient Refusal of Surgery for Early-Stage Pancreatic Cancer: An NCDB Cohort Study.
Tohme S; Kaltenmeier C; Bou-Samra P; Varley PR; Tsung A
Ann Surg Oncol; 2018 Nov; 25(12):3427-3435. PubMed ID: 30043318
[TBL] [Abstract][Full Text] [Related]
17. High BMI has no impact on the survival of Chinese patients with lower thoracic esophageal adenocarcinoma treated with curative esophagectomy: a propensity score-matched study.
Deng HY; Alai G; Li G; Luo J; Zhuo ZG; Lin YD
Dis Esophagus; 2019 Jan; 32(1):. PubMed ID: 29931316
[TBL] [Abstract][Full Text] [Related]
18. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
19. Induction therapy does not improve survival for clinical stage T2N0 esophageal cancer.
Speicher PJ; Ganapathi AM; Englum BR; Hartwig MG; Onaitis MW; D'Amico TA; Berry MF
J Thorac Oncol; 2014 Aug; 9(8):1195-201. PubMed ID: 25157773
[TBL] [Abstract][Full Text] [Related]
20. Treatment and survival outcomes of small cell carcinoma of the esophagus: an analysis of the National Cancer Data Base.
Wong AT; Shao M; Rineer J; Osborn V; Schwartz D; Schreiber D
Dis Esophagus; 2017 Feb; 30(2):1-5. PubMed ID: 27860114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
